Emerald Advisers’s VivoSim Labs VIVS Stock Holding History

Emerald Advisers’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,153	Closed	-$1.6M	–	367
2013 Q3	$1.6M	Buy	+1,153	New	+$1.61M	0.09%	216

Other funds holding VIVS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

BCM

Barometer Capital Management Toronto, Ontario, Canada $292M AUM 86.78% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AFG

American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return

Emerald Advisers's VIVS Position: Q4 2013 in Review

Emerald Advisers sold out of VivoSim Labs (VIVS) in Q4 2013, closing a stake of 1,153 shares — an estimated $1.6M sold.

Emerald Advisers first reported a position in VIVS in Q3 2013 and held it in 1 quarter. The position peaked at $1.6M in Q3 2013. 83 funds tracked by Wall St. Rank hold VIVS as of Q4 2013.

Emerald Advisers reported no remaining VivoSim Labs position as of Q4 2013 after selling out during the quarter.
Emerald Advisers sold 1,153 VivoSim Labs shares in Q4 2013, an estimated $1.6M.
Emerald Advisers first reported a position in VivoSim Labs in Q3 2013 and held it in 1 quarter.
Emerald Advisers's VivoSim Labs position peaked at $1.6M in Q3 2013.
83 funds tracked by Wall St. Rank held VivoSim Labs as of Q4 2013.

Based on Emerald Advisers's 13F filing for Q4 2013, filed 30 Jan 2014.